Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases-Reference-Cited by-同舟云学术

Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases

Published:2014-12-06 Issue:1-2 Volume:61 Page:97-103
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Rojas Carmen Maria Lara,Borella Elisabetta,Palma Lavinia,Ragozzino Silvio,De Ramón Enrique,Gomez-Huelgas Ricardo,Punzi Leonardo,Doria Andrea

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-014-8607-z.pdf

Reference46 articles.

1. Cordier JF. Cryptogenic organising pneumonia. Eur Respir J. 2006;28:422–46.

2. Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med. 2008;3:67–75.

3. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med. 2001;161:158–64.

4. King TE. Cryptogenic organizing pneumonia. In: www.uptodate.com . 2013. http://www.uptodate/contents/cryptogenic-organizing-pneumonia/contributors . (Accessed 14 Jan 2014).

5. Sveinsson OA, Isakson HJ, Gudmundsson G. Organising pneumonia—a review and results from Icelandic studies. Laeknabladid. 2008;94:27–35.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management;Clinical Reviews in Allergy & Immunology;2022-03-18

2. Secondary organizing pneumonia in a patient with postoperative bacterial pneumonia and empyema following lung cancer surgery;The Journal of the Japanese Association for Chest Surgery;2020-05-15

3. Belimumab in refractory organizing pneumonia associated with systemic lupus erythematosus: a case report;Lupus;2019-03-12

4. Rheumatische Syndrome bei verschiedenen nichtrheumatischen Erkrankungen;Differenzialdiagnose rheumatischer Erkrankungen;2019

5. PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a dose-independent manner: a meta-analysis;Scientific Reports;2017-03-08